Issue Date: May 12, 2014 | Web Date: May 9, 2014
Merck & Co. Sells Consumer Products Unit To Bayer
In the latest big pharma move to slim down, Merck & Co. will sell its consumer care business to Bayer for $14.2 billion. In a related transaction, Merck will also give Bayer $1 billion up front to codevelop a class of cardiovascular drugs.
Merck announced in January that it was considering its options for both its consumer care and animal health units, adding to a growing industry trend to . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society